Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Technology defies another dictum; shares unaffected by higher rates

Article Abstract:

For at least a year, technology stocks have defied the theory that stocks should fall when interest rates rise. Rates are higher than in late 1998 even in the face of a two-week Treasury bond rally. The Nasdaq Composite Index has tripled in less than 18 months. Still, economists and analysts still hope to make a case that a rise in interest rates is bad for the market.

Author: Berenson, Alex
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2000
Public Finance Activities, Government expenditures, Financial analysis, Federal Reserve System, Statistical Data Included, Analysis, High technology industry, Statistics, Interest rates, Technology overview, Securities, Nasdaq Composite Index (Index)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A First Experience of War In a House for the Dead

Article Abstract:

U.S. Marines speak about the impact that fighting in Iraq has had on their personal lives.

Author: Berenson, Alex
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Iraq, Beliefs, opinions and attitudes, Military aspects, Marines, Iraq War, 2003-

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Bad Medicine For Pillmakers

Article Abstract:

The pharmaceutical industry is failing in its attempts to create new drugs. Pfizer, AstraZeneca and Eli Lilly have all seen share prices drop, as they reported serious side effects from a variety of new products.

Author: Berenson, Alex
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Product development, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Sales & consumption, Financial management, Government regulation, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Drugs, Metabolic Agents NEC, Metabolic Agents, Industry Overview, Pharmaceutical industry, Finance, International aspects, Complications and side effects, Licensing, certification and accreditation, Company financing, Pharmaceutical research, Industry sales and revenue

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States
Similar abstracts:
  • Abstracts: Asian employees at Lucent are troubled by handling of arrests. F.B.I. says 3 stole secrets from Lucent
  • Abstracts: Online course lets the isolated bring their medical skills up to date. Game draws a range of protests
  • Abstracts: Air Canada stock slide continues as carrier deals with uncertainty. Air Canada creditors mull legal action over lush payouts
  • Abstracts: Just how safe is that catalog in your mailbox? The direct mail industry is working on assurances. The Ad Council, criticized for its response to Sept. 11, moves ahead with plans to remake itself
  • Abstracts: 'I Discovered what Faith and Love are Really About'. 'Life is easier if you can share the burdens.'. When you're funny, you're blessed
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.